Investments, Loans. Make, directly or indirectly, any loan or advance to or have any Investment in any Person, or make any commitment to make such loan, advance or Investment, except: (a) Equity Interests of any Credit Party acquired or issued in accordance with the other provisions of this Agreement, including without limitation, the provisions of Section 6.10 above, or Equity Interests of any other Subsidiary of any Credit Party with the prior written consent of the Agent; (b) Permitted Investment Securities; (c) loans otherwise permitted by the provisions of Section 7.1(g) above; (d) loans to employees of the Borrower or any Subsidiary made in the ordinary course of business, so long as the aggregate amount of all such loans outstanding at any time does not exceed $100,000; (e) Investments of the Borrower and the other Credit Parties permitted under the terms of Section 7.4(e)(7); (f) Investments consisting of Guarantees permitted by Section 7.3(d); (g) Investments consisting of deferred payment obligations in connection with sales of assets permitted under Section 7.4(e)(5); and (h) Other Investments, including joint venture interests in non-Subsidiary entities, in the aggregate amount not to exceed $5,000,000, provided that such Investments have been approved by the Agent, such approval not to be unreasonably withheld if the aggregate amount of such Investments does not exceed $5,000,000 in the aggregate during the period from November 10, 2010 through the Term Loan Maturity Date.
Appears in 2 contracts
Samples: Term Loan Credit Agreement (Animal Health International, Inc.), Term Loan Credit Agreement (Animal Health International, Inc.)
Investments, Loans. Make, directly or indirectly, any loan or advance to or have any Investment in any Person, or make any commitment to make such loan, advance or Investment, except:
(a) Equity Interests of any Credit Party acquired or issued in accordance with the other provisions of this Agreement, including without limitation, the provisions of Section 6.10 above, or Equity Interests of any other Subsidiary of any Credit Party with the prior written consent of the Agent;
(b) Permitted Investment Securities;
(c) loans otherwise permitted by the provisions of Section 7.1(g) above;
(d) loans to employees of the Borrower or any Subsidiary made in the ordinary course of business, so long as the aggregate amount of all such loans outstanding at any time does not exceed $100,000;
(e) Investments of the Borrower and the other Credit Parties permitted under the terms of Section 7.4(e)(7);
(f) Investments consisting of Guarantees permitted by Section 7.3(d);
(g) Investments consisting of deferred payment obligations in connection with sales of assets permitted under Section 7.4(e)(5); and
(h) Other Investments, including joint venture interests in non-Subsidiary entities, in the aggregate amount not to exceed $5,000,000500,000, provided that such Investments have been approved by the Agent, such approval not to be unreasonably withheld if the aggregate amount of such Investments does not exceed $5,000,000 500,000 in the aggregate during the period from November 10September 26, 2010 2006 through the Term Loan Maturity Date.
Appears in 2 contracts
Samples: Term Loan Agreement (Animal Health International, Inc.), Term Loan Agreement (Animal Health International, Inc.)
Investments, Loans. Make, directly or indirectly, any loan or advance to or have any Investment in any Person, or make any commitment to make such loan, advance or Investment, except:
(a) Equity Interests of any Credit Party acquired or issued in accordance with the other provisions of this Agreement, including without limitation, the provisions of Section 6.10 above, or Equity Interests of any other Subsidiary of any Credit Party with the prior written consent of the Administrative Agent;
(b) Permitted Investment Securities;
(c) loans otherwise permitted by the provisions of Section 7.1(g) above;
(d) loans to employees of the any Borrower or any Subsidiary made in the ordinary course of business, so long as the aggregate amount of all such loans outstanding for all Borrowers at any time does not exceed $100,000;
(e) Investments of the Borrower Borrowers and the other Credit Parties permitted under the terms of Section 7.4(e)(77.4(e)(9);
(f) Investments consisting of Guarantees permitted by Section 7.3(d);
(g) Investments consisting of deferred payment obligations in connection with sales of assets permitted under Section 7.4(e)(5); and
(h) Other Investments, including joint venture interests in non-Subsidiary entities, in the aggregate amount not to exceed $5,000,000500,000, provided that such Investments have been approved by the Administrative Agent, such approval not to be unreasonably withheld if (1) the aggregate amount of such Investments does not exceed $5,000,000 500,000 in the aggregate during the period from November 10, 2010 the Closing Date through the Term Loan Maturity Revolving Credit Termination Date, and (2) Aggregate Availability is $15,000,000 or greater at all times for the 90-day period prior to such Investment and immediately after giving effect to such Investment.
Appears in 2 contracts
Samples: Credit Agreement (Animal Health International, Inc.), Credit Agreement (Animal Health International, Inc.)
Investments, Loans. Make, directly or indirectly, any loan or advance to or have any Investment in any Person, or make any commitment to make such loan, advance or Investment, except:
(a) Equity Interests of any Credit Party acquired or issued in accordance with the other provisions of this Agreement, including without limitation, the provisions of Section 6.10 above, or Equity Interests of any other Subsidiary of any Credit Party with the prior written consent of the Agent;
(b) Permitted Investment SecuritiesSecurities and Permitted Affiliate Transactions;
(c) loans otherwise permitted by the provisions of Section 7.1(g) above;
(d) loans to employees of the Borrower or any Subsidiary made in the ordinary course of business, so long as the aggregate amount of all such loans outstanding at any time does not exceed $100,000;
(e) Investments of the Borrower and the other Credit Parties permitted under the terms of Section 7.4(e)(7);
(f) Investments consisting of Guarantees permitted by Section 7.3(d);
(g) Investments consisting of deferred payment obligations in connection with sales of assets permitted under Section 7.4(e)(5)assets; and
(h) Other Investments, including joint venture interests in non-Subsidiary entities, in the aggregate amount not to exceed $5,000,000500,000, provided that such Investments have been approved by the AgentLender, such approval not to be unreasonably withheld if (1) the aggregate amount of such Investments does not exceed $5,000,000 500,000 in the aggregate during the period from November 10, 2010 the Loan B Closing Date through the Term Loan B Maturity Date, and (2) Availability is $15,000,000 or greater at all times for the 90-day period prior to such Investment and immediately after giving effect to such Investment.
Appears in 1 contract
Samples: Secured Term Loan Agreement (Animal Health International, Inc.)
Investments, Loans. Make, directly or indirectly, any loan or advance to or have any Investment in any Person, or make any commitment to make such loan, advance or Investment, except:
(a) Equity Interests of any Credit Party acquired or issued in accordance with the other provisions of this Agreement, including without limitation, the provisions of Section 6.10 above, or Equity Interests of any other Subsidiary of any Credit Party with the prior written consent of the Agent;
(b) Permitted Investment Securities;
(c) loans otherwise permitted by the provisions of Section 7.1(g) above;
(d) loans to employees of the Borrower or any Subsidiary made in the ordinary course of business, so long as the aggregate amount of all such loans outstanding at any time does not exceed $100,000;
(e) Investments of the Borrower and the other Credit Parties permitted under the terms of Section 7.4(e)(7);
(f) Investments consisting of Guarantees permitted by Section 7.3(d);
(g) Investments consisting of deferred payment obligations in connection with sales of assets permitted under Section 7.4(e)(5); and
(h) Other Investments, including joint venture interests in non-Subsidiary entities, in the aggregate amount not to exceed $5,000,000500,000, provided that such Investments have been approved by the Agent, such approval not to be unreasonably withheld if (1) the aggregate amount of such Investments does not exceed $5,000,000 500,000 in the aggregate during the period from November 10, 2010 the Closing Date through the Term Loan Maturity Revolving Credit Termination Date, and (2) Availability is $15,000,000 or greater at all times for the 90-day period prior to such Investment and immediately after giving effect to such Investment.
Appears in 1 contract
Samples: Credit Agreement (Animal Health International, Inc.)
Investments, Loans. Make, directly or indirectly, any loan or advance to or have any Investment in any Person, or make any commitment to make such loan, advance or Investment, except:
(a) Equity Interests of any Credit Party acquired or issued in accordance with the other provisions of this Agreement, including without limitation, the provisions of Section 6.10 above, or Equity Interests of any other Subsidiary of any Credit Party with the prior written consent of the Agent;
(b) Permitted Investment Securities;
(c) loans otherwise permitted by the provisions of Section 7.1(g7.1 (g) above;
(d) loans to employees of the Borrower or any Subsidiary made in the ordinary course of business, so long as the aggregate amount of all such loans outstanding at any time does not exceed $100,000;
(e) Investments of the Borrower and the other Credit Parties permitted under the terms of Section 7.4(e)(7);
(f) Investments consisting of Guarantees permitted by Section 7.3(d);
(g) Investments consisting of deferred payment obligations in connection with sales of assets permitted under Section 7.4(e)(5); and
(h) Other Investments, including joint venture interests in non-Subsidiary entities, in the aggregate amount not to exceed $5,000,000500,000, provided that such Investments have been approved by the Agent, such approval not to be unreasonably withheld if (1) the aggregate amount of such Investments does not exceed $5,000,000 500,000 in the aggregate during the period from November 10, 2010 the Closing Date through the Term Loan Maturity Revolving Credit Termination Date, and (2) Availability is $15,000,000 or greater at all times for the 90-day period prior to such Investment and immediately after giving effect to such Investment.
Appears in 1 contract
Samples: Credit Agreement (Animal Health International, Inc.)